Observational study to assess quality of life in patients with pancreatic neuroendocrine tumors receiving treatment with everolimus: The OBLIQUE Study (UK Phase IV Trial)

John K. Ramage*, Pankaj Punia, Olusola Faluyi, Andrea Frilling, Tim Meyer, Ruby Saharan, Juan W. Valle

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Observational study to assess quality of life in patients with pancreatic neuroendocrine tumors receiving treatment with everolimus: The OBLIQUE Study (UK Phase IV Trial)'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science